Extrasynaptic gamma-aminobutyric acid type A receptor (Extrasynaptic GABAA receptor)

Extrasynaptic gamma-aminobutyric acid type A receptors (extrasynaptic GABAA receptors) are a distinct subclass of GABAA receptors that are predominantly localized outside synaptic junctions on neuronal membranes, where they are activated by ambient levels of the neurotransmitter GABA to generate persistent, tonic inhibitory currents[7][8]. These receptors typically contain an α4, α6, or α5 subunit in combination with β and δ subunits, conferring high affinity for GABA and unique pharmacological sensitivities compared to synaptic GABAA receptors, which commonly contain γ2 subunits[2][3][7][8]. Extrasynaptic GABAA receptors play essential roles in regulating neuronal excitability, network oscillations, and the overall level of neuronal inhibition, and are fundamental for modulating arousal, sleep, and cognitive function[2][3][8]. Dysfunction or altered expression of these receptors has been implicated in a variety of neuropsychiatric and neurological disorders, including epilepsy, mood disorders, schizophrenia, and alcohol use disorder[8][2][5]. These receptors are key targets for several classes of drugs, such as anesthetics, sedative-hypnotics, neurosteroids, and the investigational agent gaboxadol, with drugs acting as positive allosteric modulators, direct agonists, or antagonists[3][7][8]. Safety concerns arise primarily from risk of tolerance, dependence, sedation, cognitive impairment, and possible mood alterations with pharmacological manipulation of tonic inhibition[8].

Other names

Tonic GABAA receptorGABAA receptor (extrasynaptic subtype)Extrasynaptic GABA(A) receptorα4βδ GABAA receptorα6βδ GABAA receptorα5-GABAA receptor

Positive allosteric modulation (benzodiazepines, neurosteroids, barbiturates, ethanol); Direct agonism (gaboxadol); Antagonism/blockade (Ro15-4513, some inverse agonists)